{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:27:29Z","timestamp":1777577249942,"version":"3.51.4"},"reference-count":53,"publisher":"Hindawi Limited","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1986,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hum. Mutat."],"DOI":"10.1002\/humu.21245","type":"journal-article","created":{"date-parts":[[2010,3,25]],"date-time":"2010-03-25T16:16:58Z","timestamp":1269533818000},"page":"692-701","source":"Crossref","is-referenced-by-count":37,"title":["Predicting functional significance of cancer-associated p16INK4a mutations in CDKN2A"],"prefix":"10.1155","volume":"31","author":[{"given":"Heather A.","family":"McKenzie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carina","family":"Fung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Therese M.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mal","family":"Irvine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham J.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard F.","family":"Kefford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Rizos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2010,3,25]]},"reference":[{"key":"10.1002\/humu.21245-BIB1|cit1","doi-asserted-by":"crossref","first-page":"13742","DOI":"10.1073\/pnas.93.24.13742","article-title":"Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts","volume":"93","author":"Alcorta","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/humu.21245-BIB2|cit2","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/ijc.21265","article-title":"The melanoma-associated 24 base pair duplication in p16INK4a is functionally impaired","volume":"117","author":"Becker","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1002\/humu.21245-BIB3|cit3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1476-4598-8-4","article-title":"The chromatin remodelling factor BRG1 is a novel binding partner of the tumor suppressor p16INK4a","volume":"8","author":"Becker","year":"2009","journal-title":"Mol Cancer"},{"key":"10.1002\/humu.21245-BIB4|cit4","first-page":"3282","article-title":"Functional impairment of melanoma-associated p16INK4a mutants in melanoma cells despite retention of cyclin-dependent kinase 4 binding","volume":"7","author":"Becker","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1002\/humu.21245-BIB5|cit5","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/jnci\/94.12.894","article-title":"Geographical variation in the penetrance of CDKN2A mutations for melanoma","volume":"94","author":"Bishop","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1002\/humu.21245-BIB6|cit6","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.onc.1201919","article-title":"Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivation","volume":"17","author":"Brenner","year":"1998","journal-title":"Oncogene"},{"key":"10.1002\/humu.21245-BIB7|cit7","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/humu.20492","article-title":"Interpreting missense variants: comparing computational methods in human disease genes CDKN2A, MLH1, MSH2, MECP2, and tyrosinase (TYR)","volume":"28","author":"Chan","year":"2007","journal-title":"Hum Mutat"},{"key":"10.1002\/humu.21245-BIB8|cit8","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1158\/0008-5472.835.65.3","article-title":"CDKN2A common variants and their association with melanoma risk: a population-based study","volume":"65","author":"Debniak","year":"2005","journal-title":"Cancer Res"},{"key":"10.1002\/humu.21245-BIB9|cit9","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1038\/sj.onc.1201470","article-title":"Analysis of the CDKN2A, CDKN2B and CDK4 genes in 48 Australian melanoma kindreds","volume":"15","author":"Flores","year":"1997","journal-title":"Oncogene"},{"key":"10.1002\/humu.21245-BIB10|cit10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF03401664","article-title":"The CDKN2A (p16) gene and human cancer","volume":"3","author":"Foulkes","year":"1997","journal-title":"Mol Med"},{"key":"10.1002\/humu.21245-BIB11|cit11","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1093\/jnci\/djn157","article-title":"Frequent p16-Independent Inactivation of p14ARF in Human Melanoma","volume":"100","author":"Freedberg","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1002\/humu.21245-BIB12|cit12","doi-asserted-by":"crossref","first-page":"9818","DOI":"10.1158\/0008-5472.CAN-06-0494","article-title":"High-risk Melanoma Susceptibility Genes and Pancreatic Cancer, Neural System Tumors, and Uveal Melanoma across GenoMEL","volume":"66","author":"Goldstein","year":"2006a","journal-title":"Cancer Res"},{"key":"10.1002\/humu.21245-BIB13|cit13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/jmg.2006.043802","article-title":"Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents","volume":"44","author":"Goldstein","year":"2006b","journal-title":"J Med Genet"},{"key":"10.1002\/humu.21245-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1038\/sj.leu.2400840","article-title":"Inhibition of growth of human leukemia cell lines by retrovirally expressed wild-type p16INK4A","volume":"11","author":"Gombart","year":"1997","journal-title":"Leukemia"},{"key":"10.1002\/humu.21245-BIB15|cit15","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1126\/science.185.4154.862","article-title":"Amino acid difference formula to help explain protein evolution","volume":"185","author":"Grantham","year":"1974","journal-title":"Science"},{"key":"10.1002\/humu.21245-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1038\/sj.onc.1206101","article-title":"Detailed computational study of p53 and p16: using evolutionary sequence analysis and disease-associated mutations to predict the functional consequences of allelic variants","volume":"22","author":"Greenblatt","year":"2003","journal-title":"Oncogene"},{"key":"10.1002\/humu.21245-BIB17|cit17","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1474-9726.2008.00422.x","article-title":"p16INK4a-induced senescence is disabled by melanoma-associated mutations","volume":"7","author":"Haferkamp","year":"2008","journal-title":"Aging Cell"},{"key":"10.1002\/humu.21245-BIB18|cit18","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1093\/hmg\/6.12.2061","article-title":"Germline mutations of the CDKN2 gene in UK melanoma families","volume":"6","author":"Harland","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1002\/humu.21245-BIB19|cit19","doi-asserted-by":"crossref","first-page":"10915","DOI":"10.1073\/pnas.89.22.10915","article-title":"Amino acid substitution matrices from protein blocks","volume":"89","author":"Henikoff","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/humu.21245-BIB20|cit20","first-page":"2289","article-title":"Analysis of the p16 gene, CDKN2, in 17 Australian melanoma kindreds","volume":"11","author":"Holland","year":"1995","journal-title":"Oncogene"},{"key":"10.1002\/humu.21245-BIB21|cit21","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/(SICI)1098-2264(199908)25:4<339::AID-GCC5>3.0.CO;2-H","article-title":"CDKN2A (p16INK4a) and CDK4 mutation analysis in 131 Australian melanoma probands: effect of family history and multiple primary melanomas","volume":"25","author":"Holland","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1002\/humu.21245-BIB22|cit22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bbrc.2007.06.181","article-title":"Identification and characterization of a novel protein ISOC2 that interacts with p16INK4a","volume":"361","author":"Huang","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1002\/humu.21245-BIB23|cit23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/ng0994-15","article-title":"Germline p16 mutations in familial melanoma","volume":"8","author":"Hussussian","year":"1994","journal-title":"Nat Genet"},{"key":"10.1002\/humu.21245-BIB24|cit24","doi-asserted-by":"crossref","first-page":"9134","DOI":"10.1158\/0008-5472.CAN-07-1528","article-title":"A CDKN2A mutation in familial melanoma that abrogates binding of p16INK4a to CDK4 but not CDK6","volume":"67","author":"Jones","year":"2007","journal-title":"Cancer Res"},{"key":"10.1002\/humu.21245-BIB25|cit25","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/humu.20845","article-title":"Functional, structural, and genetic evaluation of 20 CDKN2A germ line mutations identified in melanoma-prone families or patients","volume":"30","author":"Kannengiesser","year":"2009","journal-title":"Hum Mutat"},{"key":"10.1002\/humu.21245-BIB26|cit26","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/375506a0","article-title":"Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition","volume":"375","author":"Koh","year":"1995","journal-title":"Nature"},{"key":"10.1002\/humu.21245-BIB27|cit27","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/sj.onc.1201570","article-title":"Active cdk6 complexes are predominantly nuclear and represent only a minority of the cdk6 in T cells","volume":"16","author":"Mahony","year":"1998","journal-title":"Oncogene"},{"key":"10.1002\/humu.21245-BIB28|cit28","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.semcdb.2007.09.003","article-title":"The endoplasmic reticulum and the unfolded protein response","volume":"18","author":"Malhotra","year":"2007","journal-title":"Semin Cell Dev Biol"},{"key":"10.1002\/humu.21245-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1128\/MCB.19.3.1981","article-title":"Induced expression of p16(INK4a) inhibits both CDK4- and CDK2-associated kinase activity by reassortment of cyclin-CDK-inhibitor complexes","volume":"19","author":"McConnell","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1002\/humu.21245-BIB30|cit30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1755-148X.2008.00530.x","article-title":"Wild type and melanoma-associated mutant p16(INK4a) proteins do not oligomerize in vivo","volume":"22","author":"McKenzie","year":"2009","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1002\/humu.21245-BIB31|cit31","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10689-007-9143-y","article-title":"BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma","volume":"6","author":"Monnerat","year":"2007","journal-title":"Fam Cancer"},{"key":"10.1002\/humu.21245-BIB32|cit32","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1046\/j.1523-1747.2000.00823.x","article-title":"Genotype\/phenotype and penetrance studies in melanoma families with germnline CDKN2A mutations","volume":"114","author":"Newton-Bishop","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1002\/humu.21245-BIB33|cit33","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/sj.jid.5700689","article-title":"CDKN2A germline mutations in individuals with cutaneous malignant melanoma","volume":"127","author":"Orlow","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1002\/humu.21245-BIB34|cit34","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1128\/MCB.16.7.3844","article-title":"Temperature-sensitive mutants of p16CDKN2 associated with familial melanoma","volume":"16","author":"Parry","year":"1996","journal-title":"Mol Cell Biol"},{"key":"10.1002\/humu.21245-BIB35|cit35","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/(SICI)1097-0215(19970220)74:1<26::AID-IJC5>3.0.CO;2-2","article-title":"p16\/CDKN2 and CDK4 gene mutations in sporadic melanoma development and progression","volume":"74","author":"Piccinin","year":"1997","journal-title":"Int J Cancer"},{"key":"10.1002\/humu.21245-BIB36|cit36","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/(SICI)1098-1004(1998)11:6<424::AID-HUMU2>3.0.CO;2-2","article-title":"Haplotype analysis of two recurrent CDKN2a mutations in 10 melanoma families: evidence for common founders and independent mutations","volume":"11","author":"Pollock","year":"1998","journal-title":"Hum Mutat"},{"key":"10.1002\/humu.21245-BIB37|cit37","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/ng0595-114","article-title":"Mutations associated with familial melanoma impair p16INK4 function","volume":"10","author":"Ranade","year":"1995","journal-title":"Nat Genet"},{"key":"10.1002\/humu.21245-BIB38|cit38","first-page":"1173","article-title":"p16 proteins from melanoma-prone families are deficient in binding to Cdk4","volume":"11","author":"Reymond","year":"1995","journal-title":"Oncogene"},{"key":"10.1002\/humu.21245-BIB39|cit39","doi-asserted-by":"crossref","first-page":"41424","DOI":"10.1074\/jbc.M105299200","article-title":"Mutations in the INK4a\/ARF melanoma susceptibility locus functionally impair p14ARF","volume":"276","author":"Rizos","year":"2001a","journal-title":"J Biol Chem"},{"key":"10.1002\/humu.21245-BIB40|cit40","doi-asserted-by":"crossref","first-page":"41424","DOI":"10.1074\/jbc.M105299200","article-title":"Mutations in the INK4a\/ARF melanoma susceptibility locus functionally impair p14ARF","volume":"276","author":"Rizos","year":"2001b","journal-title":"J Biol Chem"},{"key":"10.1002\/humu.21245-BIB41|cit41","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00008390-199902000-00003","article-title":"Multiple abnormalities of the p16INK4a-pRb regulatory pathway in cultured melanoma cells","volume":"9","author":"Rizos","year":"1999","journal-title":"Melanoma Res"},{"key":"10.1002\/humu.21245-BIB42|cit42","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.1038\/sj.onc.1204728","article-title":"A melanoma-associated germline mutation in exon 1\u03b2 inactivates p14ARF","volume":"20","author":"Rizos","year":"2001c","journal-title":"Oncogene"},{"key":"10.1002\/humu.21245-BIB43|cit43","first-page":"2092","article-title":"Increased loss of chromosome 9p21 but not p16 inactivation in primary non-small cell lung cancer from smokers","volume":"61","author":"Sanchez-Cespedes","year":"2001","journal-title":"Cancer Res"},{"key":"10.1002\/humu.21245-BIB44|cit44","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/366704a0","article-title":"A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D\/CDK4","volume":"366","author":"Serrano","year":"1993","journal-title":"Nature"},{"key":"10.1002\/humu.21245-BIB45|cit45","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/humu.20896","article-title":"Classification of rare missense substitutions, using risk surfaces, with genetic- and molecular-epidemiology applications","volume":"29","author":"Tavtigian","year":"2008a","journal-title":"Hum Mutat"},{"key":"10.1002\/humu.21245-BIB46|cit46","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/humu.20892","article-title":"In silico analysis of missense substitutions using sequence-alignment based methods","volume":"29","author":"Tavtigian","year":"2008b","journal-title":"Hum Mutat"},{"key":"10.1002\/humu.21245-BIB47|cit47","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/(SICI)1097-0215(19990719)82:2<305::AID-IJC24>3.0.CO;2-Z","article-title":"Functional reassessment of P16 variants using a transfection-based assay","volume":"82","author":"Walker","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1002\/humu.21245-BIB48|cit48","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/hmg\/4.10.1845","article-title":"Mutations of the CDKN2\/p16INK4 gene in Australian melanoma kindreds","volume":"4","author":"Walker","year":"1995","journal-title":"Hum Mol Gen"},{"key":"10.1002\/humu.21245-BIB49|cit49","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1093\/nar\/gkl091","article-title":"M-Coffee: combining multiple sequence alignment methods with T-Coffee","volume":"34","author":"Wallace","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"10.1002\/humu.21245-BIB50|cit50","doi-asserted-by":"crossref","first-page":"7563","DOI":"10.1073\/pnas.91.16.7563","article-title":"Localization of a putative tumor suppressor gene by using homozygous deletions in melanomas","volume":"91","author":"Weaver-Feldhaus","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/humu.21245-BIB51|cit51","first-page":"2503","article-title":"Mutational effects on the p16INK4a tumor suppressor protein","volume":"55","author":"Yang","year":"1995","journal-title":"Cancer Res"},{"key":"10.1002\/humu.21245-BIB52|cit52","doi-asserted-by":"crossref","first-page":"28734","DOI":"10.1074\/jbc.271.46.28734","article-title":"Defective folding of mutant p16(INK4) proteins encoded by tumor-derived alleles-communication","volume":"271","author":"Zhang","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1002\/humu.21245-BIB53|cit53","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1101\/gad.12.19.2997","article-title":"Senescence of human fibroblasts induced by oncogenic Raf","volume":"12","author":"Zhu","year":"1998","journal-title":"Genes Dev"}],"container-title":["Human Mutation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhumu.21245","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/humu.21245","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T07:14:39Z","timestamp":1685517279000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/humu.21245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,25]]},"references-count":53,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.1002\/humu.21245","relation":{},"ISSN":["1059-7794","1098-1004"],"issn-type":[{"value":"1059-7794","type":"print"},{"value":"1098-1004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,25]]}}}